ARCSA medical device registration in Ecuador for FDA-cleared and CE-marked products. Local Ecuadorian registration holder required under Resolución ARCSA-DE-026-2016-YMIH (as reformed 2023). All-inclusive annual fee.
Timelines confirmed at proposal stage
ARCSA requires a locally registered Ecuadorian company as the single registration holder. Foreign manufacturers cannot hold ARCSA registrations directly. bioaccess® holds through our own local Ecuadorian entity.
First device family low-to-mid risk USD 7,500/yr, all-inclusive. Additional families +USD 3,500/yr.
All-inclusive annual subscription includes government submission fees, in-country registered agent, regulatory liaison, and certified/sworn translations where required. Electrical/EMC and RF homologation for wireless devices are handled through the country’s telecom authority at vendor cost plus a 20% G&A handling fee.
Market Access hub · LATAM registration pricing · LATAM Importer of Record guide
Related: Clinical trials in Ecuador.